Relebactam is used as part of a combination antibiotic (with imipenem/cilastatin) to treat serious bacterial infections, especially those caused by multidrug-resistant (MDR) Gram-negative bacteria, including complicated urinary tract infections (cUTIs), complicated intra-abdominal infections (cIAIs), and hospital-acquired/ventilator-associated pneumonia (HABP/VABP). It works by protecting imipenem from bacterial enzymes (beta-lactamases), restoring its ability to kill resistant bacteria like Pseudomonas aeruginosa and carbapenem-resistant Enterobacterales (CRE). The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include relebactamum, (1R, 2S, 5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1 and 6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate. Its PubChem CID is 44129647.
Relebactam
| CAS No | 1174018-99-5 |
|---|---|
| Molecular Formula | C12H20N4O6S |
| Molecular Weight | 348.38 g/mol |
| Synonyms | [(2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Relebactam is used as part of a combination antibiotic (with imipenem/cilastatin) to treat serious bacterial infections, especially those caused by multidrug-resistant (MDR) Gram-negative bacteria, including complicated urinary tract infections (cUTIs), complicated intra-abdominal infections (cIAIs), and hospital-acquired/ventilator-associated pneumonia (HABP/VABP).
The listed CAS number is 1174018-99-5.
The listed molecular formula is C12H20N4O6S.
The listed molecular weight is 348.38 g/mol.
[(2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate.
The source lists relebactamum, (1R, 2S, 5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1 and 6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate.